NCT02171364

Brief Summary

Radiofrequency catheter ablation is highly effective in the treatment of patients with persistent atrial fibrillation. In order to decrease the recurrence rate after catheter ablation, the investigators propose to apply 'virtual' ablation on patient-specific atria by simulating 3D atrial computer model. The investigators will test with five different set of ablation methods and find successful methods for a specific patient. Then, this result will be compared to empirical catheter ablation result by randomly controlled trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at below P25 for not_applicable atrial-fibrillation

Timeline
Completed

Started Aug 2014

Shorter than P25 for not_applicable atrial-fibrillation

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 19, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 24, 2014

Completed
1 month until next milestone

Study Start

First participant enrolled

August 1, 2014

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
Last Updated

March 18, 2019

Status Verified

March 1, 2019

Enrollment Period

1.1 years

First QC Date

June 19, 2014

Last Update Submit

March 15, 2019

Conditions

Keywords

Atrial fibrillation, Virtual ablation, electrocardiography, electroanatomical mapping data

Outcome Measures

Primary Outcomes (1)

  • change of hospitalization rate

    1, 3, 6, 12, 18 and 24 months after catheter ablation and every 6 months thereafter.

Secondary Outcomes (2)

  • occurence of cardiovascular disease

    6 months

  • recurrence of AF

    6 months

Study Arms (2)

virtual simulation

EXPERIMENTAL

This intervention group is to choose the best effective method operation to patients by simulating 3D atrial computer model which consider patient's heart size and shape.

Procedure: Virtual ablation in based 3D CT of patient who diagnosed AF

conventional ablation

ACTIVE COMPARATOR

The other intervention group is to operate the atrial fibrillation by physician's personal experience, not by virtual simulation.

Procedure: conventional ablation based on physician's personal experience

Interventions

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of AF patients who performed catheter ablation of atrial fibrillation due to uncontrolled pulse rate by anti-arrhythmic drug therapy.

You may not qualify if:

  • AF patients who have severe heart deformations or blood problems.
  • The patients who had been performed catheter ablation of atrial ablation.
  • The patients who missed out to recording of 3D CT, echo and electrocardiography.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Severance Hospital

Seoul, 120-752, South Korea

Location

Related Publications (1)

  • Kim IS, Lim B, Shim J, Hwang M, Yu HT, Kim TH, Uhm JS, Kim SH, Joung B, On YK, Oh S, Oh YS, Nam GB, Lee MH, Shim EB, Kim YH, Pak HN; CUVIA-AF1 Investigators. Clinical Usefulness of Computational Modeling-Guided Persistent Atrial Fibrillation Ablation: Updated Outcome of Multicenter Randomized Study. Front Physiol. 2019 Dec 17;10:1512. doi: 10.3389/fphys.2019.01512. eCollection 2019.

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 19, 2014

First Posted

June 24, 2014

Study Start

August 1, 2014

Primary Completion

September 1, 2015

Study Completion

September 1, 2015

Last Updated

March 18, 2019

Record last verified: 2019-03

Locations